| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2009 | WO2008063746A8 Method of treatment for inflammatory bowel disease |
| 06/18/2009 | WO2008057855A9 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
| 06/18/2009 | WO2008056266A8 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 06/18/2009 | WO2008034535A8 Method for treating skin by administering an agent that decreases gmcsf release from keratinocytes |
| 06/18/2009 | WO2008009860A3 Use of calcium channel antagonist compounds for depigmenting the skin |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | WO2007027532A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/18/2009 | WO2004070002A3 Cell lines and host nucleic acid sequences related to infectious disease |
| 06/18/2009 | WO2004024082A3 Highly specific modulators of gtpases for target validation |
| 06/18/2009 | WO2004002414A3 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 06/18/2009 | WO2003075851A3 Compositions and methods for the treatment of anorectal disorders |
| 06/18/2009 | WO2003019144A3 METHODS AND COMPOSITIONS FOR SCREENING, DIAGNOSING, OR TREATING NF-λB RELATED DISEASE |
| 06/18/2009 | US20090158448 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 06/18/2009 | US20090156982 Transdermal treatment device and method |
| 06/18/2009 | US20090156862 Highly pure (R,R)-formoterol L-tartrate composition obtained by crystallizing a first polymorph of (R,R)-formoterol L-tartrate from aqueous isopropyl alcohol |
| 06/18/2009 | US20090156848 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 06/18/2009 | US20090156821 Quinazoline compounds |
| 06/18/2009 | US20090156813 Methods of preparing aripiprazole crystalline forms |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156794 Compositions and methods for activating genes of interest |
| 06/18/2009 | US20090156742 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 06/18/2009 | US20090156693 Ophthalmic compositions containing polysaccharide/borate gelling system |
| 06/18/2009 | US20090156690 Deodorizing Exfoliator |
| 06/18/2009 | US20090156689 Method of enhancing biological activity of plant extracts |
| 06/18/2009 | US20090156688 Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 06/18/2009 | US20090156687 Fab I and inhibition of apicomplexan parasites |
| 06/18/2009 | US20090156686 Composition containing higher fatty acid derivative and foods and drinks |
| 06/18/2009 | US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 06/18/2009 | US20090156684 Liquid antibacterial compositions incorporating trichlorocarbanilide with reduced water activity |
| 06/18/2009 | US20090156683 Fast release solid formulation, preparation and use thereof |
| 06/18/2009 | US20090156681 Compounds for the treatment of metabolic disorders |
| 06/18/2009 | US20090156680 Deodorants Containing Aminoacid Derivatives |
| 06/18/2009 | US20090156679 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 06/18/2009 | US20090156678 Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino] propanamides |
| 06/18/2009 | US20090156677 Gabapentin-containing Solid Compositions and Process for Preparing the Same |
| 06/18/2009 | US20090156676 Organic salts of beta-alanine |
| 06/18/2009 | US20090156675 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 06/18/2009 | US20090156674 Valnemulin Salts with Organic Acids |
| 06/18/2009 | US20090156673 Anti-inflammatory actions of neuroprotectin d1/protectin d1 and it's natural stereoisomers |
| 06/18/2009 | US20090156672 Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities |
| 06/18/2009 | US20090156671 Deuterium-enriched oxybutynin |
| 06/18/2009 | US20090156670 Nonaqueous liquid parenteral aceclofenac formulation |
| 06/18/2009 | US20090156668 Ginkgolide Compounds, Compositions, And Extracts, And Uses Thereof |
| 06/18/2009 | US20090156667 Method of treating asthma, allergic rhinitis, and skin disorders |
| 06/18/2009 | US20090156666 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/18/2009 | US20090156665 Compositions Comprising Flavonoids and Toctrienols and Methods Thereof |
| 06/18/2009 | US20090156664 Natural Vitamin E Compositions with Superior Antioxidant Potency |
| 06/18/2009 | US20090156663 Functional Foods Comprising Flavonoids and Tocotrienols and Methods Thereof |
| 06/18/2009 | US20090156662 Fat Absorption Inhibitor |
| 06/18/2009 | US20090156661 Compositions and Methods for Treatment and Prevention of Metabolic Syndrome and its Associated Conditions with Combinations of Flavonoids, Liminoids and Tocotrienols |
| 06/18/2009 | US20090156660 Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof |
| 06/18/2009 | US20090156659 System and method for collecting, storing, processing, transmitting and presenting very low amplitude signals |
| 06/18/2009 | US20090156658 Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals |
| 06/18/2009 | US20090156657 Anti-inflammatory composition |
| 06/18/2009 | US20090156656 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 06/18/2009 | US20090156655 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (4-[1-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-yloxy)-3,3-dimethyl-butyl]-N-(1H-tetrazol-5-ylmethyl)-benzamide |
| 06/18/2009 | US20090156654 Derivative n-thiolated 2-oxazolidinone antibiotics |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/18/2009 | US20090156652 Therapeutic agent for food competence disorder in stomach |
| 06/18/2009 | US20090156650 Composition that comprises at least one oxime and its use in therapeutics |
| 06/18/2009 | US20090156649 Cellular phosphorylation potential enhancing compositions preparation and use thereof |
| 06/18/2009 | US20090156648 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA) |
| 06/18/2009 | US20090156647 Method for maintaining physiological pH levels during intensive physical exercise |
| 06/18/2009 | US20090156646 Pyridylphenol compound and use thereof |
| 06/18/2009 | US20090156645 Method for Increasing the Susceptibility of Peptide Deformylase Inhibitors by Using Efflux Pump Inhibitors |
| 06/18/2009 | US20090156644 Use of thiazole derivatives and analogues in the treatment of cancer |
| 06/18/2009 | US20090156642 5-Membered heterocyclic compound |
| 06/18/2009 | US20090156641 Inhibition of cyclooxygenase-2 activity |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156639 Compositions and methods of treatment using l-type calcium channel blockers and cholinesterase inhibitors |
| 06/18/2009 | US20090156638 Uses of nordihydroguaiaretic acid (NDGA) and derivatives thereof in preventing transmission of sexually transmitted diseases |
| 06/18/2009 | US20090156637 Butyrophenones and sigma-1 receptor antagonists protect against oxidative-stress |
| 06/18/2009 | US20090156636 Therapeutic agent for glomerular disease |
| 06/18/2009 | US20090156635 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators |
| 06/18/2009 | US20090156634 Tropane alkaloids and trigonelline combinations and methods for administering the same |
| 06/18/2009 | US20090156633 Heterocyclic quinolone derivatives that inhbit prolyl hydroxylase activity |
| 06/18/2009 | US20090156632 Dosage regimen for prasugrel |
| 06/18/2009 | US20090156631 Controlled Release Compositions Containing Zolpidem |
| 06/18/2009 | US20090156630 Anti-tumour polycyclic carboxamides |
| 06/18/2009 | US20090156628 Aminothiazoles and their Uses |
| 06/18/2009 | US20090156627 Therapeutic compounds |
| 06/18/2009 | US20090156626 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 06/18/2009 | US20090156625 Novel Use of a Nicotinic Receptor Agonist 156 |
| 06/18/2009 | US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 06/18/2009 | US20090156623 N-aryl piperidine substituted biphenylcarboxamides |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156621 Hcv inhibitors |
| 06/18/2009 | US20090156620 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 06/18/2009 | US20090156619 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 06/18/2009 | US20090156618 1-(1- (2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino) - 1H-Pyrazolo [4,3-D] Pyrimidin-5-YL) Piperidine-4-Carboxylic acid and salts thereof |
| 06/18/2009 | US20090156617 Tyrosine kinase inhibitors |
| 06/18/2009 | US20090156616 Therapeutic agents |
| 06/18/2009 | US20090156615 Organic compounds |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090156613 Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor |
| 06/18/2009 | US20090156612 Substituted imidazole compound and use thereof |
| 06/18/2009 | US20090156611 Mammalian hedgehog signaling modulators |
| 06/18/2009 | US20090156610 Spiroindolinone Derivatives |
| 06/18/2009 | US20090156609 Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperzaine compounds |
| 06/18/2009 | US20090156607 2-oxo-1-pyrrolidine derivatives |